In Vivo CAR T Cell Generation For Cancer And Auto-Immune Treatments
With immunotherapy increasingly making it out of the lab and into hospitals as a viable way to treat…
Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3 Asset and $175M in Funding
Vor Biopharma, a cancer cell therapy developer that laid off nearly all of its employees in a wind…
WellTheory Secures $5M, Introduces New AI Tools to Support Autoimmune Care
WellTheory, a digital health company addressing autoimmune disease, has raised $5 million in funding and has launched two…